Thrive Capital’s $516 million 2022 early-stage fund has grown to more than $3.7 billion as of the end of June, a more than sevenfold increase after early bets on OpenAI, SpaceX, and Anduril Industries.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.